The FDA announced the appointment of George Tidmarsh, a veteran biotech executive and oncologist, as director of the Center for Drug Evaluation and Research (CDER). Tidmarsh’s extensive background spans oncology and pediatrics, having previously led drug development programs and served as CEO of biotech firms including La Jolla Pharmaceutical Company and Horizon Pharma. FDA Commissioner Marty Makary praised Tidmarsh's expertise across scientific, regulatory, and operational domains, anticipating strong leadership amid ongoing drug development challenges.